| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5899581 | Diabetes Research and Clinical Practice | 2014 | 24 Pages |
Abstract
Oral D3 supplementation in type 2 diabetes was associated with transient improvement in glycaemia, but without a measurable change in beta-cell function this effect is unlikely to be biologically significant. High dose D3 therefore appears to offer little or no therapeutic benefit in type 2 diabetes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Shirley Elkassaby, Leonard C. Harrison, Namita Mazzitelli, John M. Wentworth, Peter G. Colman, Timothy Spelman, Spiros Fourlanos,